Phase I pilot trial comparing the pharmacokinetics of controlled-release morphine and oxycodone with sustained-release morphine [MS Contin 30mg] and oxycodone [Oxycontin 20mg]
Phase of Trial: Phase I
Latest Information Update: 10 May 2010
At a glance
- Drugs Morphine; Oxycodone
- Indications Pain
- Focus Pharmacokinetics
- 10 May 2010 Subject number added, as reported in a QRxPharma media release.
- 10 May 2010 Status changed from recruiting to completed, as reported in a QRxPharma media release.
- 30 Mar 2010 New trial record